Thyroid Hormone Receptors Suppress Pituitary Tumor Transforming Gene 1 Activity in Hepatoma
Authors:
- 13 March 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (6) , 1697-1706
Abstract
Pituitary tumor transforming gene 1 (PTTG1) is expressed in most tumors. However, whether thyroid hormone (T3) and its receptors (TR) regulate PTTG1 in human hepatocellular carcinomas (HCC) remains unclear. Previous cDNA microarrays revealed PTTG1 is down-regulated by T3/TR. This study investigated the significance of PTTG1 regulation by T3 in HCC cells. The PTTG1 mRNA and protein expression were repressed by T3 in HCC cell lines overexpressing TR. However, after knockdown of TRs expression by RNA interference, PTTG1 repression by T3 was abolished. Similar results were observed in thyroidectomized rats. To localize the regulatory region in the PTTG1 promoter, serial deletions within the PTTG1 promoter region were constructed. The promoter activity of the PTTG1 gene was repressed (25–51%) by T3. Additionally, these findings indicate that PTTG1 may be regulated by Sp1. The critical role of the −594 and −520 Sp1 binding sites was confirmed by electrophoretic mobility shift assay. Transfection with Sp1 expression vector enhanced the activity of the PTTG1 promoter fragment reporter. Also, Sp1 was down-regulated in HCC cells and in thyroidectomized rat after T3 treatment. Additionally, ectopic expression of PTTG1 promotes cell proliferation in Hep3B hepatoma cells. Conversely, knockdown of PTTG1 or Sp1 expression reduced cell proliferation in HepG2 cells. Notably, the expression of PTTG1 and Sp1 was inversely correlated with the expression of TR proteins in HCC. Together, these findings indicate that PTTG1 gene expression is mediated by Sp1 and is indirectly down-regulated by T3. Finally, overexpression of PTTG1 or SP1 in HCCs is TR-dependent and crucial in the development of HCC. [Cancer Res 2008;68(6):1697–1706]Keywords
This publication has 37 references indexed in Scilit:
- Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transitionOncogene, 2007
- Novel functions of thyroid hormone receptor mutants: Beyond nucleus-initiated transcriptionSteroids, 2007
- Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone β receptor inhibits mitotic progressionJournal of Clinical Investigation, 2006
- Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivoHepatology, 2006
- Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis†Hepatology, 2006
- Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-betaJournal of Molecular Endocrinology, 2005
- Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by ?-catenin /TCF pathway in human esophageal squamous cell carcinomaInternational Journal of Cancer, 2004
- Thyroid hormone receptors/THR genes in human cancerCancer Letters, 2003
- hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasiasOncogene, 1999
- Expression and function of thyroid hormone receptor variants in normal and chronically diseased human liverThe Journal of Clinical Endocrinology & Metabolism, 1996